Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024.
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024. The proceeds will be#
The proceeds will be used to refinance the €500 million bond maturing on 17 March 2014.
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024. The proceeds will be#
The terms are laid down in the €4 billion Debt Issuance Program of Royal DSM, the final terms and the supplements thereto, which are available on the Investor Relations website.
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024. The proceeds will be#
The re-offer price was 99.555%. Based on this price the yield is 2.425%. The bond will be listed on Euronext Amsterdam shortly.
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024. The proceeds will be#
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously.
Royal DSM, the global Life Sciences and Materials Sciences company, has successfully issued a €500 million 2.375% bond due 2024. The proceeds will be#
Royal DSM
marketing@alchempro.com
